ADC Weekly Digest - 8 to 14 June 2024

ADC Weekly Digest - 1 to 14 June 20248

Commercial
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Clinical
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for...
Regulatory
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 as Monotherapy for Advanced...